Outcome | Yes (n,%) | Unadjusted analysis | Adjusted analysis † | ||
---|---|---|---|---|---|
Odds ratio* (95% CI) | p value | Odds ratio† (95% CI) | p value | ||
mRS ≥ 2 at 3 months (n,%) | |||||
2w3 m A group | 40/476(8.40) | – | – | – | – |
B group | 22/210(10.48) | 1.01(0.65-1.56) | 0.98 | 0.89(0.56-1.42) | 0.64 |
C group | 6/50(12.00) | 1.36(0.67-2.75) | 0.396 | 1.37(0.66-2.87) | 0.40 |
D group | 58/318(18.24) | 2.17(1.56-3.02) | < 0.0001** | 1.75(1.21-2.51) | 0.003** |
3 m SIS-16 < Q1 at 3 months | |||||
2w3 m A group | 100/476(21.01) | – | – | – | – |
B group | 62/210(29.52) | 1.34(0.99-1.81) | 0.05 | 1.18(0.85-1.63) | 0.32 |
C group | 11/50(22.00) | 1.54(0.93-2.56) | 0.10 | 1.40(0.81-2.43) | 0.23 |
D group | 111/318(34.91) | 1.99(1.55-2.56) | < 0.0001** | 1.38(1.04-1.83) | 0.025* |